Catherine H Van Poznak
Associate Professor of Internal Medicine
Department of Internal Medicine, Division of Hematology/Oncology
1500 E. Medical Center Dr
Ann Arbor, MI 48109-5848
[email protected]

Available to mentor
Catherine H Van Poznak
Associate Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials.
      Rugo HS, Van Poznak CH, Neven P, Danielewicz I, Lee SC, Campone M, Chik JYK, Vega Alonso E, Naume B, Brain E, Siegel JM, Li R, Uema D, Wagner VJ, Coleman RE. Breast Cancer Res Treat, 2024 Apr; 204 (2): 249 - 259. DOI:10.1007/s10549-023-07147-z
      PMID: 38123789
    • Presentation
      “Bone Health TeleECHO Program at AUB & AUBMC: Breast and Prostate Cancer and Bone"
      2024 Feb 26;
    • Presentation
      Sequencing of Endocrine and Targeted Therapies in Hormone-Sensitive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
      2023 Nov;
    • Journal Article
      Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG).
      Schröder CP, van Leeuwen-Stok E, Cardoso F, Linderholm B, Poncet C, Wolff AC, Bjelic-Radisic V, Werutsky G, Abreu MH, Bozovic-Spasojevic I, den Hoed I, Honkoop AH, Los M, Leone JP, Russell NS, Smilde TJ, van der Velden AWG, Van Poznak C, Vleugel MM, Yung RL, Coens C, Giordano SH, Ruddy KJ. Oncologist, 2023 Oct 3; 28 (10): e877 - e883. DOI:10.1093/oncolo/oyad152
      PMID: 37310797
    • Journal Article
      Checkpoint Inhibitors in Bone Metastatic Disease in Solid Tumors.
      Wytiaz V, Van Poznak C. Curr Osteoporos Rep, 2023 Aug; 21 (4): 323 - 329. DOI:10.1007/s11914-023-00798-3
      PMID: 37294479
    • Journal Article
      Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.
      El-Hajj Fuleihan G, Clines GA, Hu MI, Marcocci C, Murad MH, Piggott T, Van Poznak C, Wu JY, Drake MT. J Clin Endocrinol Metab, 2023 Feb 15; 108 (3): 507 - 528. DOI:10.1210/clinem/dgac621
      PMID: 36545746
    • Proceeding / Abstract / Poster
      182P Radium-223 (223Ra) in combination with exemestane and everolimus (EXE-EVE) in patients (pts) with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (MBC) with bone metastases: A phase II study
      Rugo HS, Drumea K, Lee SC, Campone M, Van Poznak C, Neven P, Alonso EV, Naume B, Siegel JM, Li R, Uema D, Wagner VJ, Coleman RE. Annals of Oncology, 2022 May; 33: s211 - s212. DOI:10.1016/j.annonc.2022.03.201
    • Journal Article
      Pharmacologic management of metastatic bone disease.
      Schwartz E, Reichert Z, Van Poznak C. Bone, 2022 May; 158: 115735 DOI:10.1016/j.bone.2020.115735
      PMID: 33171313